Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $11.36 billion. The enterprise value is $11.58 billion.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SRPT has 95.52 million shares outstanding. The number of shares has increased by 13.80% in one year.
Current Share Class | 95.52M |
Shares Outstanding | 95.52M |
Shares Change (YoY) | +13.80% |
Shares Change (QoQ) | +1.32% |
Owned by Insiders (%) | 4.47% |
Owned by Institutions (%) | 91.45% |
Float | 91.15M |
Valuation Ratios
The trailing PE ratio is 97.53 and the forward PE ratio is 15.14.
PE Ratio | 97.53 |
Forward PE | 15.14 |
PS Ratio | 7.03 |
Forward PS | 3.90 |
PB Ratio | 9.30 |
P/TBV Ratio | 9.52 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 95.04 |
EV / Sales | 7.06 |
EV / EBITDA | 96.77 |
EV / EBIT | 142.92 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.84, with a Debt / Equity ratio of 1.16.
Current Ratio | 3.84 |
Quick Ratio | 2.45 |
Debt / Equity | 1.16 |
Debt / EBITDA | 7.11 |
Debt / FCF | n/a |
Interest Coverage | 4.23 |
Financial Efficiency
Return on equity (ROE) is 12.27% and return on invested capital (ROIC) is 2.11%.
Return on Equity (ROE) | 12.27% |
Return on Assets (ROA) | 1.51% |
Return on Capital (ROIC) | 2.11% |
Revenue Per Employee | $1.25M |
Profits Per Employee | $92,728 |
Employee Count | 1,314 |
Asset Turnover | 0.49 |
Inventory Turnover | 2.55 |
Taxes
In the past 12 months, SRPT has paid $7.56 million in taxes.
Income Tax | 7.56M |
Effective Tax Rate | 5.84% |
Stock Price Statistics
The stock price has increased by +24.52% in the last 52 weeks. The beta is 0.75, so SRPT's price volatility has been lower than the market average.
Beta (5Y) | 0.75 |
52-Week Price Change | +24.52% |
50-Day Moving Average | 123.03 |
200-Day Moving Average | 129.67 |
Relative Strength Index (RSI) | 43.28 |
Average Volume (20 Days) | 1,081,965 |
Short Selling Information
The latest short interest is 5.82 million, so 6.09% of the outstanding shares have been sold short.
Short Interest | 5.82M |
Short Previous Month | 5.04M |
Short % of Shares Out | 6.09% |
Short % of Float | 6.38% |
Short Ratio (days to cover) | 4.45 |
Income Statement
In the last 12 months, SRPT had revenue of $1.64 billion and earned $121.85 million in profits. Earnings per share was $1.22.
Revenue | 1.64B |
Gross Profit | 609.29M |
Operating Income | 81.03M |
Pretax Income | 62.22M |
Net Income | 121.85M |
EBITDA | 119.67M |
EBIT | 81.03M |
Earnings Per Share (EPS) | $1.22 |
Full Income Statement Balance Sheet
The company has $1.20 billion in cash and $1.41 billion in debt, giving a net cash position of -$216.47 million or -$2.27 per share.
Cash & Cash Equivalents | 1.20B |
Total Debt | 1.41B |
Net Cash | -216.47M |
Net Cash Per Share | -$2.27 |
Equity (Book Value) | 1.22B |
Book Value Per Share | 12.79 |
Working Capital | 1.99B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$352.49 million and capital expenditures -$117.91 million, giving a free cash flow of -$470.40 million.
Operating Cash Flow | -352.49M |
Capital Expenditures | -117.91M |
Free Cash Flow | -470.40M |
FCF Per Share | -$4.92 |
Full Cash Flow Statement Margins
Gross margin is 37.14%, with operating and profit margins of 4.94% and 7.43%.
Gross Margin | 37.14% |
Operating Margin | 4.94% |
Pretax Margin | 7.89% |
Profit Margin | 7.43% |
EBITDA Margin | 7.30% |
EBIT Margin | 4.94% |
FCF Margin | n/a |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13.80% |
Shareholder Yield | -13.80% |
Earnings Yield | 1.07% |
FCF Yield | -4.14% |
Dividend Details Analyst Forecast
The average price target for SRPT is $179.38, which is 50.78% higher than the current price. The consensus rating is "Buy".
Price Target | $179.38 |
Price Target Difference | 50.78% |
Analyst Consensus | Buy |
Analyst Count | 21 |
Revenue Growth Forecast (5Y) | 23.89% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 0.1666666:1.
Last Split Date | Jul 12, 2012 |
Split Type | Reverse |
Split Ratio | 0.1666666:1 |
Scores
SRPT has an Altman Z-Score of 2.38 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.38 |
Piotroski F-Score | 5 |